Natixis Advisors LLC Acquires 170,566 Shares of CVS Health Co. (NYSE:CVS)

Natixis Advisors LLC raised its holdings in CVS Health Co. (NYSE:CVS) by 25.2% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 846,208 shares of the pharmacy operator’s stock after acquiring an additional 170,566 shares during the quarter. Natixis Advisors LLC owned approximately 0.07% of CVS Health worth $53,210,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in CVS. Livelsberger Financial Advisory bought a new stake in CVS Health during the 3rd quarter valued at about $31,000. Reston Wealth Management LLC bought a new stake in CVS Health during the 3rd quarter valued at $32,000. First Community Trust NA lifted its holdings in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares during the period. Kathleen S. Wright Associates Inc. bought a new position in shares of CVS Health during the 3rd quarter worth $33,000. Finally, ORG Partners LLC grew its holdings in CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 592 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CVS has been the topic of several research reports. Wells Fargo & Company cut their price objective on shares of CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a report on Monday, November 4th. Barclays reduced their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Royal Bank of Canada dropped their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday. UBS Group boosted their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Finally, StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $72.44.

CVS Health Trading Down 3.4 %

Shares of NYSE:CVS opened at $53.19 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25. The stock has a market cap of $66.93 billion, a price-to-earnings ratio of 13.50, a PEG ratio of 0.92 and a beta of 0.55. The business has a 50-day moving average price of $59.23 and a 200-day moving average price of $58.66.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the company posted $2.21 earnings per share. Equities analysts predict that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 5.00%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.